Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRT vs GSK✓SelectedUSD · GSKVRT vs GSK performance historyLatest closeAs of+2.16%11/18
Stock and ETF performance explorer

VRT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+635.1%
GSK return
+42.7%
Excess return
+592.4%
Maximum drawdown
-69.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.2%-1.3%+3.5%+2.2%
7D-5.8%-3.1%-2.7%-5.7%
30D-5.6%-0.9%-4.7%-5.7%
3M-28.6%-4.2%-24.5%-28.4%
6M-42.7%-1.6%-41.1%-43.1%
YTD+20.1%+2.6%+17.5%+18.6%
1Y+18.1%+6.2%+11.9%+15.8%
3Y+351.0%+55.0%+296.0%+292.9%
5Y+635.1%+42.8%+592.3%+501.2%
All+635.1%+42.7%+592.4%+501.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling